The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Tolerance of concurrent CDK inhibitor and radiation therapy in metastatic breast cancer patients.
 
Arnaud Beddok
No Relationships to Disclose
 
Alexandre Arsene-Henry
No Relationships to Disclose
 
Baptiste Porte
No Relationships to Disclose
 
Kim Cao
No Relationships to Disclose
 
Nathaniel Scher
No Relationships to Disclose
 
Joelle Otz
No Relationships to Disclose
 
Mathieu Minsat
No Relationships to Disclose
 
Francois Clement Bidard
Consulting or Advisory Role - AstraZeneca; Lilly; Pfizer
Speakers' Bureau - Amgen; Amgen; AstraZeneca; Novartis; Pfizer
Research Funding - Menarini Silicon Biosystems (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst)
Patents, Royalties, Other Intellectual Property - MSI and ESR1 detection by ddPCR (patents pending) (Inst)
Travel, Accommodations, Expenses - Amgen; AstraZeneca; Menarini Silicon Biosystems; Pfizer; Roche
 
Alain Fourquet
No Relationships to Disclose
 
Paul H. Cottu
Honoraria - Lilly; NanoString Technologies (Inst); Novartis (Inst); Pfizer; Roche
Consulting or Advisory Role - Lilly; Pfizer; Roche/Genentech
Research Funding - Novartis (Inst); pfizer (Inst)
Travel, Accommodations, Expenses - pfizer; Roche
 
Youlia Kirova
Research Funding - AstraZeneca (Inst)
Travel, Accommodations, Expenses - Accuray; Roche